RCUS
Arcus Biosciences, Inc.
NYSE · Healthcare · Biotechnology · US
$25.24
−1.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 102.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.93x
- Price / sales
- 27.47x
- Price / cash flow
- -6.78x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 22.44x
- EV / EBITDA
- -6.27x
- EV / EBIT
- -5.40x
- Market cap
- $3.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026